During the past ten years, the treatment of erysipelas has been the subject of repeated investigation and discussion. The World War, no doubt, was a big factor in bringing this about, as erysipelas was a common and severe complicating factor of infections in wounds.
The discovery that light had physicochemical potentials which were extremely active and which evidently had powerfully potent therapeutic possibilities naturally led to the thought that this agent could be useful in the treatment of a patient with a condition such as erysipelas.
Again, more recently, the immunologic studies of diphtheria and scarlet fever and the great advances, from a diagnostic and therapeutic standpoint, made in the treatment of patients with these conditions have led investigators to attempt similar therapeutic procedures in erysipelas.
Although it is well recognized that erysipelas is definitely a selflimited disease and that it does not ordinarily present a serious problem in the
PLATOU ES, SCHLUTZ FW, COLLINS L. ERYSIPELAS: A CLINICAL STUDY OF THE TREATMENT OF THIS DISEASE. Am J Dis Child. 1927;34(6):1030–1039. doi:10.1001/archpedi.1927.04130240109014
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: